Anticoagulation Treatment and Outcomes of VTE by Weight and BMI:
Insights From the VA

Perino AC, Fan J, Schmitt S, Guo JD, Hlavacek P, Din N, Kothari M, Pundi K,
Russ C, Emir B, and Turakhia MP.
Objective: Real-world use of DOACs for VTE across the body size spectrum for patients at extremes of body weight and BMI Clinical variables that predict DOAC prescriptions for patients who weigh >120 kg or have a BMI >40 kg/m2 and variation in DOAC prescriptions across VA sites for VTE Association of body size with major bleeding, CRNM bleeding, and recurrent VTE after initiation of an OAC for VTE